Farmington, NMNCT07541170Now EnrollingIRB Ready

Non-small Cell Lung Cancer Clinical Trial in Farmington, NM

Access cutting-edge non-small cell lung cancer treatment through this phase 3 clinical trial at a research site in Farmington. Study-provided care at no cost to qualified participants.

Sponsored by Hoffmann-La Roche

Quick Self-Assessment

See if you qualify for this Farmington location

Preparing your pre-screening questions…

Expert Care in Farmington

Access non-small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer treatment provided free

Apply for This Farmington Location

Check if you qualify for this non-small cell lung cancer clinical trial in Farmington, NM

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Farmington

    Convenient for NM residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Farmington site if eligible
  4. 4Begin participation

About This Non-small Cell Lung Cancer Study in Farmington

The main purpose of this study is to evaluate the efficacy of divarasib compared with investigator's choice of immunotherapy (pembrolizumab or nivolumab) or observation in participants with resected Kirsten rat sarcoma viral oncogene homolog glycine 12 to cysteine (KRAS G12C)-positive Stage II-IIIB NSCLC, regardless of tumor programmed death-ligand 1 (PD-L1) status, who have not achieved pathologic complete response (pCR) following neoadjuvant chemoimmunotherapy.

Sponsor: Hoffmann-La Roche

Who Can Participate

Inclusion Criteria

Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1
Histological or cytological diagnosis of clinical Stage II-IIIB NSCLC of either non-squamous or squamous histology
Participants must have had complete resection of NSCLC
Prior treatment with neoadjuvant immune checkpoint inhibitor (pembrolizumab or nivolumab) in combination with histology-based platinum-based doublet chemotherapy
Participants must be randomized within 12 weeks of their surgery date
No evidence of disease recurrence or metastatic disease
Documentation of the presence of a KRAS G12C mutation

Exclusion Criteria

Participants who achieve pCR following neoadjuvant treatment
Prior treatment with a KRAS inhibitor or any other anti-cancer therapy not otherwise specified in the protocol
Prior treatment with radiation therapy for NSCLC, with the exception of localized symptom-directed radiation prior to surgical resection
Resolved Grade 3 or greater immune-related AE or unresolved Grade 2 or greater immune-related AE from neoadjuvant immunotherapy
Active or history of autoimmune disease or immune deficiency
Significant cardiovascular disease

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Farmington?

Yes, this clinical trial (NCT07541170) has an active research site in Farmington, NM that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-small Cell Lung Cancer Treatment Options in Farmington, NM

If you're searching for non-small cell lung cancer treatment options in Farmington, NM, this clinical trial (NCT07541170) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Farmington research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Farmington, NM

See all lung cancer clinical trials recruiting in Farmington — not just this study.

Browse Lung Cancer Trials in Farmington →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Farmington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Farmington, NM